NCT00213655View on ClinicalTrials.gov

URO-BCG-4 : Bladder Tumors Immunotherapy

CompletedOBSERVATIONAL
Enrollment

146

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

May 31, 2013

Study Completion Date

December 31, 2013

Conditions
Bladder Cancer
Interventions
BIOLOGICAL

bladder tumor recurrence

bladder tumor recurrence assessed by clinical and biological exams

Trial Locations (1)

76031

Charles Nicolle, University Hospital, Rouen

All Listed Sponsors
lead

University Hospital, Rouen

OTHER

NCT00213655 - URO-BCG-4 : Bladder Tumors Immunotherapy | Biotech Hunter | Biotech Hunter